NewsHantavirus cases spark surge in pharma and biotech stocks — here’s why Posted on May 11, 2026 by budd87309@gmail.com The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines. budd87309@gmail.com Cerebras bumps up IPO range as it looks to raise up to $4.8 billion April home sales disappoint as higher mortgage rates weigh on buyers
